Eisai ESALF Stock
Eisai Price Chart
Eisai ESALF Financial and Trading Overview
| Eisai stock price | 29.9 USD |
| Previous Close | 29.9 USD |
| Open | 29.9 USD |
| Bid | 29.5 USD x 30000 |
| Ask | 30.33 USD x 42500 |
| Day's Range | 29.9 - 29.9 USD |
| 52 Week Range | 23.88 - 35.83 USD |
| Volume | 100 USD |
| Avg. Volume | 67 USD |
| Market Cap | 8.44B USD |
| Beta (5Y Monthly) | -0.052 |
| PE Ratio (TTM) | 34.76744 |
| EPS (TTM) | 0.86 USD |
| Forward Dividend & Yield | 1.01 (3.39%) |
| Ex-Dividend Date | September 29, 2026 |
| 1y Target Est | N/A |
ESALF Valuation Measures
| Enterprise Value | -5362484224 USD |
| Trailing P/E | 34.76744 |
| Forward P/E | 23.730158 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.0098463185 |
| Price/Book (mrq) | 1.477389 |
| Enterprise Value/Revenue | -0.006 |
| Enterprise Value/EBITDA | -0.056 |
Trading Information
Eisai Stock Price History
| Beta (5Y Monthly) | -0.052 |
| 52-Week Change | -6.21% |
| S&P500 52-Week Change | 18.15% |
| 52 Week High | 35.83 USD |
| 52 Week Low | 23.88 USD |
| 50-Day Moving Average | 26.46 USD |
| 200-Day Moving Average | 28.71 USD |
ESALF Share Statistics
| Avg. Volume (3 month) | 67 USD |
| Avg. Daily Volume (10-Days) | 10 USD |
| Shares Outstanding | 282.24M |
| Float | 281.16M |
| Short Ratio | N/A |
| % Held by Insiders | 2.18% |
| % Held by Institutions | 56.58% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 160 |
| Trailing Annual Dividend Yield | 535.11% |
| 5 Year Average Dividend Yield | 281.00% |
| Payout Ratio | 1.1698 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2026 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | March 31, 2027 |
Profitability
| Profit Margin | 4.93% |
| Operating Margin (ttm) | 10.55% |
| Gross Margin | 76.69% |
| EBITDA Margin | 11.21% |
Management Effectiveness
| Return on Assets (ttm) | 2.39% |
| Return on Equity (ttm) | 4.96% |
Income Statement
| Revenue (ttm) | 857.06B USD |
| Revenue Per Share (ttm) | 3040.39 USD |
| Quarterly Revenue Growth (yoy) | 15.59% |
| Gross Profit (ttm) | 657.35B USD |
| EBITDA | 96.13B USD |
| Net Income Avi to Common (ttm) | 42.33B USD |
| Diluted EPS (ttm) | 0.86 |
| Quarterly Earnings Growth (yoy) | 26.00% |
Balance Sheet
| Total Cash (mrq) | 311.74B USD |
| Total Cash Per Share (mrq) | 1105.89 USD |
| Total Debt (mrq) | 271.34B USD |
| Total Debt/Equity (mrq) | 29.08 USD |
| Current Ratio (mrq) | 2.243 |
| Book Value Per Share (mrq) | 20.238407 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 57.64B USD |
| Levered Free Cash Flow (ttm) | -27565625344 USD |
Profile of Eisai
| Country | United States |
| State | N/A |
| City | Tokyo |
| Address | 4-6-10 Koishikawa |
| ZIP | 112-8088 |
| Phone | 81 3 3817 3700 |
| Website | https://www.eisai.co.jp |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 10543 |
Eisai Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals in Japan. The company operates through pharmaceuticals business and other business segments. It offers Lenvima, a multi-kinase inhibitor which is involved in tumor angiogenesis or tumor malignancy; LEQEMBI, a humanized IgG1 monoclonal antibody against amyloid-beta (Aß) protofibrils; and Dayvigo, a novel small molecule compound. The company also provides prescription drugs; and over-the-counter drugs, as well as focuses on neurology and oncology, and other therapeutic areas. It operates in Europe, the Middle East, Africa, Russia, Oceania, the Americas, China, East Asia, the Global South, and internationally. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.
Q&A For Eisai Stock
What is a current ESALF stock price?
Eisai ESALF stock price today per share is 29.9 USD.
How to purchase Eisai stock?
You can buy ESALF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Eisai?
The stock symbol or ticker of Eisai is ESALF.
Which industry does the Eisai company belong to?
The Eisai industry is Drug Manufacturers - Specialty & Generic.
How many shares does Eisai have in circulation?
The max supply of Eisai shares is 282.24M.
What is Eisai Price to Earnings Ratio (PE Ratio)?
Eisai PE Ratio is 34.76744000 now.
What was Eisai earnings per share over the trailing 12 months (TTM)?
Eisai EPS is 0.86 USD over the trailing 12 months.
Which sector does the Eisai company belong to?
The Eisai sector is Healthcare.
